October 24, 2014
SAN DIEGO — Safety and uncertainty involving the risk for hepatitis B are reasons for barriers to vaccine uptake, according to recent study findings presented at the 2014 AAP National Conference and Exhibition.
“Universal hepatitis B vaccination is recommended beginning in the immediate post-natal period,” Bronwyn Baz, MD, of Oregon Health and Science University, wrote in the abstract. “Refusal remains a barrier to universal inoculation. Studying the qualities of groups refusing vaccines, including hepatitis B, may be helpful in identifying strategies for uptake improvement. We assessed uptake of the newborn hepatitis vaccine … with the goal of assessing reasons for refusal and identifying potential interventions.”